157 related articles for article (PubMed ID: 35837891)
1. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer After Total Neoadjuvant Therapy (TNT).
Peacock O; Manisundaram N; Dibrito SR; Kim Y; Hu CY; Bednarski BK; Konishi T; Stanietzky N; Vikram R; Kaur H; Taggart MW; Dasari A; Holliday EB; You YN; Chang GJ
Ann Surg; 2022 Oct; 276(4):654-664. PubMed ID: 35837891
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
[TBL] [Abstract][Full Text] [Related]
3. Robotic lateral pelvic lymph node dissection after chemoradiation for rectal cancer: a Western perspective.
Peacock O; Limvorapitak T; Bednarski BK; Kaur H; Taggart MW; Dasari A; Holliday EB; Minsky BD; You YN; Chang GJ
Colorectal Dis; 2020 Dec; 22(12):2049-2056. PubMed ID: 32892473
[TBL] [Abstract][Full Text] [Related]
4. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
[TBL] [Abstract][Full Text] [Related]
5. Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?
Law BZY; Yusuf Z; Ng YE; Aly EH
Int J Colorectal Dis; 2020 Aug; 35(8):1387-1395. PubMed ID: 32504333
[TBL] [Abstract][Full Text] [Related]
6. Comparison between preoperative chemoradiotherapy and lateral pelvic lymph node dissection in clinical T3 low rectal cancer without enlarged lateral lymph nodes.
Tsukada Y; Rullier E; Shiraishi T; Capdepont M; Sasaki T; Celerier B; Denost Q; Ito M
Colorectal Dis; 2023 Jun; 25(6):1153-1162. PubMed ID: 36932710
[TBL] [Abstract][Full Text] [Related]
7. Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer.
Nakanishi R; Akiyoshi T; Toda S; Murakami Y; Taguchi S; Oba K; Hanaoka Y; Nagasaki T; Yamaguchi T; Konishi T; Matoba S; Ueno M; Fukunaga Y; Kuroyanagi H
Ann Surg Oncol; 2020 Oct; 27(11):4273-4283. PubMed ID: 32767224
[TBL] [Abstract][Full Text] [Related]
8. Lateral pelvic lymph node dissection in the management of locally advanced low rectal cancer: Summary of the current evidence.
Elhusseini M; Aly EH
Surg Oncol; 2020 Dec; 35():418-425. PubMed ID: 33038847
[TBL] [Abstract][Full Text] [Related]
9. Functional outcomes after lateral pelvic lymph node dissection for rectal cancer: a systematic review and meta-analysis.
Cribb BI; Kong J; McCormick J; Warrier SK; Heriot AG
Int J Colorectal Dis; 2022 Mar; 37(3):583-595. PubMed ID: 34846550
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of indocyanine green fluorescence imaging-guided laparoscopic lateral pelvic lymph node dissection for clinical stage II/III middle-lower rectal cancer: a propensity score-matched cohort study.
Watanabe J; Ohya H; Sakai J; Suwa Y; Goto K; Nakagawa K; Ozawa M; Ishibe A; Suwa H; Kunisaki C; Endo I
Tech Coloproctol; 2023 Sep; 27(9):759-767. PubMed ID: 36773172
[TBL] [Abstract][Full Text] [Related]
11. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.
Yamamoto T; Kawada K; Hida K; Ganeko R; Inamoto S; Yoshitomi M; Watanabe T; Sakai Y
Int J Clin Oncol; 2019 Jun; 24(6):677-685. PubMed ID: 30721379
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic treatment of rectal cancer and lateral pelvic lymph node dissection: are they obsolete?
Toda S; Kuroyanagi H; Matoba S; Hiramatsu K; Okazaki N; Tate T; Tomizawa K; Hanaoka Y; Moriyama J
Minerva Chir; 2018 Dec; 73(6):558-573. PubMed ID: 29795062
[TBL] [Abstract][Full Text] [Related]
13. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
[TBL] [Abstract][Full Text] [Related]
14. Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer.
Dharmarajan S; Shuai D; Fajardo AD; Birnbaum EH; Hunt SR; Mutch MG; Fleshman JW; Lin AY
J Gastrointest Surg; 2011 Aug; 15(8):1368-74. PubMed ID: 21533959
[TBL] [Abstract][Full Text] [Related]
15. Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.
Sekido Y; Nishimura J; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Haraguchi N; Hata T; Matsuda C; Mizushima T; Murata K; Hasegawa J; Mori M; Doki Y
Surg Today; 2020 Mar; 50(3):292-297. PubMed ID: 31595366
[TBL] [Abstract][Full Text] [Related]
16. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
[TBL] [Abstract][Full Text] [Related]
17. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of laparoscopic lateral pelvic lymph node dissection on urinary retention in rectal cancer.
Sadakari Y; Hisano K; Sada M; Mizuuchi Y; Nagayoshi K; Fujita H; Nagai S; Manabe T; Ueki T; Nakamura M
Surg Endosc; 2022 Feb; 36(2):999-1007. PubMed ID: 33616731
[TBL] [Abstract][Full Text] [Related]
19. Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI.
Ogawa S; Itabashi M; Hirosawa T; Hashimoto T; Bamba Y; Kameoka S
J Surg Oncol; 2014 Mar; 109(3):227-33. PubMed ID: 24165955
[TBL] [Abstract][Full Text] [Related]
20. The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum.
Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Sugihara K
Int J Colorectal Dis; 2016 Oct; 31(10):1719-28. PubMed ID: 27576475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
